COVID-19 OQIBATIDA O’LIM XAVFI OMILLARINI INTEGRAL BAXOLASH
##article.subject##:
diabet, COVID-19, kasallik og’irligi, o'lim havfi##article.abstract##
Aktuallik: COVID-19 va qandli diabet o’rtasidagi bog’liqlik COVID-19 og’ir kechuvi, pnevmoniyа, o’tkit respirator distress sindrom (O’RDS) va o’lim havfini ortishi bilan namoyon bo’ladi.
Maqsad: Тошкент шахри мисолида умумий ахоли ва 2-тур кандли диабет билан касалланган беморлар орасида COVID 19 окибатида улим хавфи омилларини o’rganish.
Materiallar va usullar: Tadqiqotga 2020-yilda hujjatda tasdiqlangan ( PCR testi) koronavirus infeksiyasini o’tkazgan 5023 nafar kishi olingan.
Natijalar va munozaralar: Qandli diabetning mavjudligi o'lim xavfini 4,33 martaga, erkak jinsida koronavirus infektsiyasi tufayli o'lim xavfini 3,70 baravarga, semirishning mavjudligi o'lim xavfini 2,99 martaga, yurak tomirlari kasalligining mavjudligini sezilarli darajada oshirdi,YuIK-5,63 baravarga, gipertenziya mavjudligi - 1,85 marta.
Xulosa: Qandli diabet bilan og'rigan bemorlar qattiq nazoratni va COVID-19 kasalligi uchun xavfni baholashni talab qiladi. Nafas siqishi, ko'krak qafasidagi og'riqlar, vazn yo'qotish va taxiaritmiya paydo bo'lishi umumiy populyatsiyada ham, 2-tur diabet bilan og'rigan bemorlarda ham yuqori o'lim xavfi bilan bog'liq.
Библиографические ссылки
Barron E, Bakhai C, Kar P, Weaver A, Bradley D, Ismail H, Knighton P, Holman N, Khunti K, Sattar N, Wareham NJ, Young B, Valabhji J. Type 1 and type 2 diabetes and COVID-19 related mortality in England: a whole population study. Available from: https://www.england.nhs.uk/wp-content/uploads/2020/05/Valabhji-COVID-19-and-Diabetes-Paper-2-Full-Manuscript.pdf
Barron E., Bakhai Ch., Kar P., Weaver A., Bradley D., Ismail H., Knighton P., Holman N., Khunti K., Sattar N., Wareham N.J., Young B., Valabhji J. Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study. www.thelancet.com/diabetes-endocrinology Vol 8 October 2020 813-822 doi:10.1016/S2213-8587(20)30272-2
Guo W., Li M. , Dong Y., Zhou H., Zhang Z., Tian C. , et al. Diabetes is a risk factor for the progression and prognosis of COVID-19. Diabetes Metab Res Rev (2020), Article e3319, 10.1002/dmrr.3319
Li B., Yang J., Zhao F., Zhi L., Wang X., Liu L. , et al. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol (2020), 10.1007/s00392-020-01626-9
Wu Z., McGoogan J.M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA. (2020), 10.1001/jama.2020.2648
Zhou F., Yu T., Du R. , Fan G., Liu Y., Liu Z., et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet., 395 (2020), pp. 1054-1062, 10.1016/s0140-6736(20)30566-3
Hajibeygi, R., Mirghazanfari, S. M., Pahlavani, N., Jalil, A. T., Alshahrani, S. H., Rizaev, J. A., ... & Yekta, N. H. (2022). Effect of a diet based on Iranian traditional medicine on inflammatory markers and clinical outcomes in COVID-19 patients: A double-blind, randomized, controlled trial. European Journal of Integrative Medicine, 102179.
Зейнитдинова, З. А., РИЗАЕВ, Ж. А., & Орипов, Ф. С. (2022). Степень цитологического поражения эпителия слизистой оболочки щеки при COVID-19. ЖУРНАЛ БИОМЕДИЦИНЫ И ПРАКТИКИ, 7(2).
Umirzakov Zokir, Rizaev Jasur, UMIROV Safar. The phenomenon of the epidemic
covid-19 process and their leading determinants. Journal of Biomedicine and Practice. 2021, vol. 6, issue 6, pp. 286-295
Ризаев, ж. А., Кушаков, Б. Ж., Рустамова, Д. А. (2022). Проявления коронавирусной инфекции SARS-COV-2 в полости рта. Журнал биомедицины и практики, 7(2).
Умирзаков, З., Ризаев, Ж., Умиров, С., & Рустамова, Д. (2022). ОРГАНИЗАЦИЯ МЕДИЦИНСКИХ УСЛУГ В ЭПИДЕМИЧЕСКОМ ЦЕНТРЕ COVID-19. Журнал стоматологии и краниофациальных исследований, 2(3), 67–73. https://doi.org/10.26739.2181-0966-2021-3-13
